Ascom wins major Ascom Myco 3 order with contract extension in the UK

Sep 1, 2020

Ascom and British digital care technology specialist Person Centred Software have signed a contract extension, which includes the shipment of several thousand Ascom Myco 3 handsets. The contract extension amounts to CHF 3.9 million.

The contract with Person Centred Software (PCS) is to be extended for two further years until the end of 2022. The contract extension includes provision of several thousand additional units of the Ascom Myco 3 smartphone for care personnel in long-term care.

Ascom Myco 3 smartphones together with supported apps unlock and connect siloed information, helping to share information across dispersed teams and coordinate time sensitive activities. Multi-step and multi-location activities turn into coordinated workflows and communication.

Paul Lawrence, Managing Director of Ascom UK, says: “The contract extension shows significant success in our close partnership with PCS, and confirms the solid market position Ascom has in the UK in supplying long-term care facilities with sophisticated communication solutions.”

Jonathan Papworth, Co-Founder and Director of PCS, says: "Our partnership with Ascom provides our customers with an incredibly low total cost of ownership for their handheld devices, and opens up the world of interoperability between all the systems in use in a care home. We are confident that the Ascom Myco 3 provides the best possible handset available to long-term care providers in terms of functionality, security and costs."





This document does not constitute an offer or solicitation to subscribe for, purchase or sell any securities. This document is not being issued in the United States of America or the United Kingdom and should not be distributed in any jurisdiction in a manner where such distribution would not comply with regulatory requirements. In particular, this document may not be distributed into the United States, to United States persons or to publications with a general circulation in the United States. In addition, the securities of Ascom have not been and will not be registered in any jurisdiction outside Switzerland. The securities of Ascom may not be offered, sold or delivered and no solicitation to purchase such securities may be made within the United States or to U.S. persons absent an applicable exemption from the registration requirements of the United States securities laws or within any other jurisdiction and in a manner where such offer, sale, delivery or solicitation might not be in compliance with regulatory requirements (including the United Kingdom).